CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 5 enrolled
Drug / intervention
PegInterferon +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01704521
NCT01704521Phase 1Completed
CompareCT.gov

Viral Kinetic Models of HCV Clearance in Hemophiliacs With Telaprevir

Kenneth Sherman·interventional·Posted Oct 11, 2012·Updated Apr 6, 2015

In Brief

A Phase 1 clinical trial evaluating PegInterferon, Ribavirin, and 1 other intervention for Chronic Hepatitis C and Hemophilia. Completed, enrolled 5 participants across 1 site.

Detailed Summary

This study will examine viral dynamic responses in subjects with chronic hepatitis C and hemophilia when treated with pegylated interferon + ribavirin and telaprevir.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis C, Hemophilia
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), Vertex Pharmaceuticals Incorporated, Genentech, Inc.

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 11, 2012
Enrollment StartDec 1, 2012
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.7 years ago

Interventions

PegInterferondrug

Ribavirindrug

Telaprevirdrug